These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 18508489)

  • 21. Aβ40(L17A/F19A) mutant diminishes the aggregation and neurotoxicity of Aβ40.
    Chen YR; Huang HB; Lo CJ; Wang CC; Su CL; Liu HT; Shiao MS; Lin TH; Chen YC
    Biochem Biophys Res Commun; 2011 Feb; 405(1):91-5. PubMed ID: 21216230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stabilities and conformations of Alzheimer's beta -amyloid peptide oligomers (Abeta 16-22, Abeta 16-35, and Abeta 10-35): Sequence effects.
    Ma B; Nussinov R
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14126-31. PubMed ID: 12391326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the Tottori familial disease mutation (D7N) on the monomers and dimers of Aβ40 and Aβ42.
    Viet MH; Nguyen PH; Ngo ST; Li MS; Derreumaux P
    ACS Chem Neurosci; 2013 Nov; 4(11):1446-57. PubMed ID: 24041307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abeta40-Lactam(D23/K28) models a conformation highly favorable for nucleation of amyloid.
    Sciarretta KL; Gordon DJ; Petkova AT; Tycko R; Meredith SC
    Biochemistry; 2005 Apr; 44(16):6003-14. PubMed ID: 15835889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibril elongation by Aβ(17-42): kinetic network analysis of hybrid-resolution molecular dynamics simulations.
    Han W; Schulten K
    J Am Chem Soc; 2014 Sep; 136(35):12450-60. PubMed ID: 25134066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The structure of the Alzheimer amyloid beta 10-35 peptide probed through replica-exchange molecular dynamics simulations in explicit solvent.
    Baumketner A; Shea JE
    J Mol Biol; 2007 Feb; 366(1):275-85. PubMed ID: 17166516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Point substitution in the central hydrophobic cluster of a human beta-amyloid congener disrupts peptide folding and abolishes plaque competence.
    Esler WP; Stimson ER; Ghilardi JR; Lu YA; Felix AM; Vinters HV; Mantyh PW; Lee JP; Maggio JE
    Biochemistry; 1996 Nov; 35(44):13914-21. PubMed ID: 8909288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High pressure NMR reveals conformational perturbations by disease-causing mutations in amyloid β-peptide.
    Rosenman DJ; Clemente N; Ali M; García AE; Wang C
    Chem Commun (Camb); 2018 May; 54(36):4609-4612. PubMed ID: 29670961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Weaker N-Terminal Interactions for the Protective over the Causative Aβ Peptide Dimer Mutants.
    Sharma B; Ranganathan SV; Belfort G
    ACS Chem Neurosci; 2018 Jun; 9(6):1247-1253. PubMed ID: 29465978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alzheimer's Protective Cross-Interaction between Wild-Type and A2T Variants Alters Aβ
    Das P; Chacko AR; Belfort G
    ACS Chem Neurosci; 2017 Mar; 8(3):606-618. PubMed ID: 28292185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of the Arctic (E22-->G) mutation on amyloid beta-protein folding: discrete molecular dynamics study.
    Lam AR; Teplow DB; Stanley HE; Urbanc B
    J Am Chem Soc; 2008 Dec; 130(51):17413-22. PubMed ID: 19053400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Side chain interactions can impede amyloid fibril growth: replica exchange simulations of Abeta peptide mutant.
    Takeda T; Klimov DK
    J Phys Chem B; 2009 Sep; 113(35):11848-57. PubMed ID: 19708712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the A2V Mutation on the Heterozygous and Homozygous Aβ1-40 Dimer Structures from Atomistic Simulations.
    Nguyen PH; Sterpone F; Campanera JM; Nasica-Labouze J; Derreumaux P
    ACS Chem Neurosci; 2016 Jun; 7(6):823-32. PubMed ID: 27007027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation in the conformational and stability attributes of the Alzheimer's disease associated amyloid-beta mutants and their favorable stabilization by curcumin: molecular dynamics simulation analysis.
    Awasthi M; Singh S; Pandey VP; Dwivedi UN
    J Biomol Struct Dyn; 2018 Feb; 36(2):407-422. PubMed ID: 28054501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amyloid β-Protein Assembly: Differential Effects of the Protective A2T Mutation and Recessive A2V Familial Alzheimer's Disease Mutation.
    Zheng X; Liu D; Roychaudhuri R; Teplow DB; Bowers MT
    ACS Chem Neurosci; 2015 Oct; 6(10):1732-40. PubMed ID: 26244608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Density functional theory analysis and spectral studies on amyloid peptide Abeta(28-35) and its mutants A30G and A30I.
    Nagarajan S; Rajadas J; Malar EJ
    J Struct Biol; 2010 Jun; 170(3):439-50. PubMed ID: 20188180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Charge alterations of E22 enhance the pathogenic properties of the amyloid beta-protein.
    Melchor JP; McVoy L; Van Nostrand WE
    J Neurochem; 2000 May; 74(5):2209-12. PubMed ID: 10800967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular insights into the effect L17A/F19A double mutation on the structure and dynamics of Aβ
    Saini RK; Shuaib S; Goyal D; Goyal B
    J Cell Biochem; 2018 Nov; 119(11):8949-8961. PubMed ID: 30076733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Site-specific identification of non-beta-strand conformations in Alzheimer's beta-amyloid fibrils by solid-state NMR.
    Antzutkin ON; Balbach JJ; Tycko R
    Biophys J; 2003 May; 84(5):3326-35. PubMed ID: 12719262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flexibility and Solvation of Amyloid-β Hydrophobic Core.
    Vugmeyster L; Clark MA; Falconer IB; Ostrovsky D; Gantz D; Qiang W; Hoatson GL
    J Biol Chem; 2016 Aug; 291(35):18484-95. PubMed ID: 27402826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.